04/05/2024 | Press release | Distributed by Public on 04/05/2024 02:37
The eMIT provides information about prices and usage for generic drugs and pharmaceutical products.
This tool gives background information on the pharmaceuticals that hospitals might buy.
The data provided includes:
The data within the eMIT represents the 12-month period to the end of December 2023.
The data has been manipulated to protect the confidentiality of framework agreement prices where necessary.
Spreadsheet updated with data from the 12-month period to the end of December 2023.
Document updated with data from the 12-month period to the end of June 2023.
Document updated with data from the 12-month period to the end of December 2022.
Document updated with data from the 12-month period to the end of June 2022.
Document updated with data from the 12-month period to the end of June 2021.
Replaced document and changed date.
Document updated with data from the 12-month period to the end of December 2019.
Document updated with data from the 12-month period to the end of June 2019.
Document updated with data from the 12-month period to the end of December 2018.
Document updated with data from the 12-month period to the end of June 2018.
Document updated with data from the 12-month period to the end of June 2017.
Document updated with the latest market information.
The data within the eMIT represents the 12 month period to the end of December 2015.
The data within the eMIT represents the 12 month period to the end of June 2015.
First published.